Cohort study

Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United States Population

JACC Cardiovasc IntervPublished

  • Retrospective cohort study
  • single-centre
  • registry
  • risk score validation

Authors' conclusion

In a large PCI registry, the BCIS-CHIP score had a good predictive value for MACCE at 1 year.

Study context

Population
Consecutive patients undergoing percutaneous coronary intervention (PCI) at a large tertiary care centre, US, 2011–2020
Participants
20,799 patients
Exposure
BCIS-CHIP score categories
Outcome
MACCE:
  • All-cause death
  • MI
  • Stroke
Follow-up
1 year

Main finding

As reported in the abstract

MACCE
Each group vs score 0Hazard ratio (95% CI)
Score 1-2
1.72(1.32–2.24)
Score 3-4
3.60(2.78–4.66)
Score ≥5
7.40(5.75–9.51)
Increase in MACCE risk per point increase of BCIS-CHIP score
28.0%
C-index for 1-year MACCE
0.70

Observational data: associations, not effects.

Secondary outcomes

Individual MACCE components and major bleeding · 1 year

Risk progressively increased with higher score values

Original publication

Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United States Population. JACC Cardiovasc Interv. Published 8 May 2023. doi:10.1016/j.jcin.2023.02.005

Summarised from the published abstract; every number is checked against it